Source: http://www.biocopy.de/
Timestamp: 2019-04-18 15:15:35+00:00

Document:
Time is a crucial issue in vaccine development. In order to save as many lives as possible, we want to realize a faster process for finding vaccine candidates, preferably reducing the time needed therefor from months to merely '48 hours'.
With our patented biomolecule copier, we are able to copy DNA of pathogens (e.g. virus, bacteria) in to a microarray. In a second copying step, taking place in a microfluidic chamber, we convert the DNA into a protein microarray, which displays all pathogen proteins. Subsequently, we add a drop of blood from a survivor of the given disease. Naturally, the survivor’s blood contains high amounts of protecting antibodies against the pathogen. Thus, these antibodies will bind to all proteins enabling immunity. Such proteins are potential vaccine candidates – found within '48 hours'.
We bring the vaccine candidate finding process to a new level, with faster analysis and higher coverage making us all prepared for the next outbreaks after Ebola (2015) and Zika (2016).
Core values are part of a company’s DNA. They should be self-evident and within one's own heart and mind.
[in-teg-ri-tee] derives from the old Latin word "integritas" and even at that time it basically meant – to be whole - and as such authentic, to follow a righteous path of honesty, truthfulness and accuracy and having strong moral principles.
Integrity is the essence for being a trustworthy and responsible partner, employer, employee, colleague and customer. It is not always easy to follow this inner sense of wholeness and rightness, but we will not compromise these values for higher profits or to strengthen our market position. Therefore, at the end of the day, we can look into the mirror and wear a contented smile - knowing that we are still whole and hoping to be on the right way - for us and all others.
A fulfilling workplace to come to each day, one that excites employees, inspires them in creativity and offers them growth and development is the foundation of a pleasant and creative atmosphere. We embrace diversity and personal development, recognize and reward individual contributions to corporate values and achievements.
Employees benefit amongst others from inspiring working spaces, free drinks, food, snacks, flexible and family-friendly working arrangements. When you come and leave with a smile every day, we did it right.
We welcome mavericks, entrepreneurial mindsets, risk takers, change makers, tinkerers and everyone with passion, who does not seek a job but a calling. Combined with mindful leadership we encourage our team members to bring all their talents to work and to become truly engaged co-creators on our journey.
We believe that long term success can only be reached if a company’s performance is in balance with benefits for humans and the environment. A conscious business model is based on a triple bottom line combining the values people, planet and profit.
BioCopy, for instance, introduces stock shares for employees to provide them with special appreciation, rewards for suggestions to save resources and environment-friendly mobility. As a purpose-driven company we want to have a long-lasting impact and leave a legacy.
We are committed to excellence and high quality and support activities enhancing the intellectual and social competence of employees. This includes international conferences, internships to partners, team building events, lectures, personal and professional workshops. We are thriving for cutting edge technologies and breakthrough innovations. Our hierarchies are built on competence, not on title.
BioCopy consists of a diverse team of different genders and education - engineers, biologists, physicists and businessmen. We promote an open and free exchange of views and ideas. Acting beyond one’s own scope of responsibilities as well as inspiring others to succeed and develop is appreciated.
A key component is to create an environment where teamwork can flourish through open, honest, regular and prompt communication. If you like to explore the end of the world with us, you are at the right place.
Professionell begleitete Hightech-Ausgründungen als Königsweg.
A Peptide-functionalized polymer as a minimal scaffold protein to enhance cluster formation in early T cell signal transduction.
Gründen an Universitäten: Der Königsweg des Technologietransfers.
Protein microarray generation by in situ protein expression from template DNA.
Real-time PCR based detection of a panel of food-borne pathogens on a centrifugal microfluidic "LabDisk" with on-disk quality controls and standards for quantification.
Strohmeier, O.; Marquart, N.; Mark, D.; Roth, G.; Zengerle, R.; Stetten, F. v.
Human Papillomavirus DNA and Host Gene mRNA Biomarker Detection in a "Micro Total Analysis System" (microTAS) Device to Aid Diagnosis of Cervical Intraepithelial Neoplasia.
Keegan H. and Roth, G. and many others et. al.
A Quantitative Assessment of Costimulation and Phosphatase Activity on Microclusters in Early T Cell Signaling.
Witsenburg, J.J.; Glauner, H. ; Muller, J.P.; Groenewoud, J.M.M.; Roth, G.; Bohmer, FD (Boehmer, Frank-Dietmar)[ 2 ] ; Adjobo-Hermans, M.J.W. ; Brock, R.
Feedstock and Biocatalyst Optimization Starts with an Integrated Genome Data Management Platform.
Centrifugal gas-phase transition magnetophoresis (GTM)‐a generic method for automation of magnetic bead based assays on the centrifugal microfluidic platform and application to DNA purification.
Multiplex genotyping of KRAS point mutations in tumor cell DNA by allele-specific real-time PCR on a centrifugal microfluidic disk segment.
Strohmeier, O.; Laßmann, S.; Riedel, B.; Mark, D.; Roth, G.; Werner, M. et al.
Bubble Jet agent release cartridge for chemical single cell stimulation.
Wangler, N.; Welsche, M.; Blazek, M.; Blessing, M.; Vervliet-Scheebaum, M.; Reski, R., Roth, G. et al.
Mediator probe PCR: a novel approach for detection of real-time PCR based on label-free primary probes and standardized secondary universal fluorogenic reporters.
Faltin, B.; Wadle, S.; Roth, G.; Zengerle, R.; Stetten, F. v.
Universal protocol for grafting PCR primers onto various lab-on-a-chip substrates for solid-phase PCR.
Hoffmann, J.; Hin, S.; Stetten, F. v.; Zengerle, R.; Roth, G.
Solid-phase PCR in a picowell array for immobilizing and arraying 100000 PCR products to a microscope slide.
Hoffmann, J.; Trotter, M.; Stetten, F. v.; Zengerle, R.; Roth, G.
Construction of a Microstructured Collagen Membrane Mimicking the Papillary Dermis Architecture and Guiding Keratinocyte Morphology and Gene Expression.
Lammers, G.; Roth, G.; Heck, M.; Zengerle, R.; Tjabringa, G. S.; Versteeg, E. M. et al.
Centrifugo-dynamic inward pumping of liquids on a centrifugal microfluidic platform.
Zehnle, S.; Schwemmer F.; Roth, G.; Stetten, F. v. et.al.
Nanotechnology-based biosensors and diagnostics: technology push versus industrial/healthcare requirements.
Vashist, S. K.; Venkatesh, A. G.; Mitsakakis, K.; Czilwik, G.; Roth, G.; Stetten, F. v.; Zengerle, R.
Beijing, China; IEEE: Piscataway, NJ, 2011.
Controlled counter-flow motion of magnetic bead chains rolling along microchannels.
Karle, M.; Wöhrle, J.; Miwa, J.; Paust, N.; Roth, G.; Zengerle, R.; Stetten, F. v.
Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.
Lorenz, C.; Fotin-Mleczek, M.; Roth, G.; Becker, C.; Dam, T. C.; Verdurmen, W. P. R. et al.
Antineuronal antibodies in sporadic late-onset cerebellar ataxia.
Bürk, K.; Wick, M.; Roth, G.; Decker, P.; Voltz, R.
Focke, M.; Stumpf, F.; Faltin, B.; Reith, P.; Bamarni, D.; Wadle, S., Roth, G.; et al.
Centrifugal microfluidic system for primary amplification and secondary real-time PCR.
Focke, M.; Stumpf, F.; Roth, G.; Zengerle, R.; Stetten, F. v.
Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells.
Hoff, A.; Bagû, A.-C.; André, T.; Roth, G.; Wiesmüller, K.-H.; Gückel, B.; Brock, R.
Continuous microfluidic DNA extraction using phase-transfer magnetophoresis.
Karle, M.; Miwa, J.; Czilwik, G.; Auwärter, V.; Roth, G.; Zengerle, R.; Stetten, F.v.
Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation.
Leemhuis, J.; Bouché, E.; Frotscher, M.; Henle, F.; Hein, L.; Herz, J.; Roth, G.; et al.
Lutz, S.; Weber, P.; Focke, M.; Faltin, B.; Hoffmann, J.; Müller, C., Roth, G.; et al.
Lab-on-a-chip solutions designed for being operated on standard laboratory instruments.
Mark, D.; Focke, M.; Lutz, S.; Burger, J.; Müller, M.; Riegger, L., Roth, G; et al.
Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications.
Mark, D.; Haeberle, S.; Roth, G.; Stetten, F. v.; Zengerle, R.
Physiologische Assays in einem DVD Player am Beispiel der Messung des Hämatokrit.
Burger, J.; Mark, D.; Roth, G.; Müller, C.; Zengerle, R.; Stetten, F. von; Park, Y.
Bürk, K.; Farecki, M.-L.; Lamprecht, G.; Roth, G.; Decker, P.; Weller, M. et al.
Natural Killer Cell Signal Integration Balances Synapse Symmetry and Migration.
Culley, F. J.; Johnson, M.; Evans, J. H.; Kumar, S.; Crilly, R.; Casasbuenas, J., Roth, G.; et al.
Diffusion-Driven Device for a High-Resolution Dose- Response Profiling of Combination Chemotherapy.
Ganser, A.; Roth, G.; van Galen, J. C; Hilderink, J.; Wammes, J. J. G.; MuĚller, I. et al.
Mikrofluidik-Plattform zur kontinuierlichen Aufreinigung von Biomolekülen.
Karle, M.; Miwa, J.; Haeberle, S.; Roth, G.; Zengerle, R.; Stetten, F. v.
Kontinuierlich arbeitende Mikrofluidik-Plattform zur Aufreinigung von Biomolekülen.
Karle, M.; Miwa, J.; Roth, G.; Haeberle, S.; Zengerle, R.; Stetten, F. v.
Isothermal Polymerase Amplification in a Centrifugal Microfluidic Foil Cartridge.
Lutz, S.; Weber, P.; Focke, M.; Faltin, B.; Roth, G.; Piepenburg, O. et al.
Lab-on-a-Chip Foundry Service: Schnelle kundenspezifische Implementierung miniaturisierter biochemischer Assays.
Metz, T.; Karle, M.; Preis, T.; Mark, D.; Roth, G.; Müller, C. et al.
Stimulus Dependence of the Action of Small-Molecule Inhibitors in the CD3/CD28 Signalling Network.
Köhler, K.; Ganser, A.; André, T.; Roth, G.; Grosse-Hovest, L.; Jung, G.; Brock, R.
Ubiquitin Binds to a Short Peptide Segment of Hydrolase UCH-L3: A Study by FCS, RIfS, ITC and NMR.
Roth, G.; Freund, S.; Möhrle, B.; Wöllner, K.; Brünjes, J.; Gauglitz, G. et al.
Heeren, A.; Luo, C. P.; Roth, G.; Ganser, A.; Brock, R.; Wiesmüller, K-H et al.
Measuring biomolecular binding events with a compact disc player device.
Lange, S. A.; Roth, G.; Wittemann, S.; Lacoste, T.; Vetter, A.; Grässle, J. et al.
Microsystems for the analysis of cellular signal transduction.
Ganser, A.; Roth, G.; Köhler, K.; André, T.; Heeren, A.; Henschel, W. et al.
These are our partners of the first hour, which have been on our side even before BioCopy came to life.

References: v.

 v.

 v. 
 v.

 v.

 v.

 v.